Watch Ticker

Innoviva, Inc. Common Stock

Go to Innoviva, Inc. Common Stock Website

$20.00

0.35 (1.78%)

Live

Previous Close

$19.65

Day Range

$19.5 - $20.115

Previous Day Range

$18.885 - $20.04

Market Cap

$1.2 billion USD

Day Vol.

1.2 million

Previous Day Vol.

1.7 million

Currency

USD

Primary Exchange

Nasdaq

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Na - Innoviva (INVA) Q2 Sales Jump 64%

Innoviva reported Q2 2025 earnings with $0.77 EPS and $100.3 million revenue, exceeding analyst expectations. Specialty therapeutics sales increased 54% year-over-year, driven by new product launches like GIAPREZA and ZEVTERA, while operating income declined due to increased R&D expenses.

Related tickers: INVA, ARMP.

Read Full Article

N/A - Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States

Basilea Pharmaceutica Ltd has entered into an exclusive distribution and license agreement with Innoviva Specialty Therapeutics, Inc. for the commercialization of Basilea's hospital anti-MRSA antibiotic Zevtera® (ceftobiprole) in the United States.

Related tickers: INVA.

Read Full Article

Trending Tickers

Please sign in to view